Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder
| Autor: | Javier Vargas-Medrano, Gloria V. Herrera, Guadalupe Vidal-Martinez, Silver M. Martin, C. Annette Reyes, Stephanie A. Chaparro, Ruth G. Perez, Carolina Gil-Tommee |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Detrusor muscle Male medicine.medical_specialty Substantia nigra Mice Transgenic Article 03 medical and health sciences Mice 0302 clinical medicine Developmental Neuroscience Parkinsonian Disorders Internal medicine Gangliosides medicine Animals Urinary Bladder Neurogenic Mice Knockout Urinary bladder Tyrosine hydroxylase business.industry Pars compacta Dopaminergic Neurons Dopaminergic medicine.disease Ventral tegmental area 030104 developmental biology Endocrinology medicine.anatomical_structure Neurology Overactive bladder N-Acetylgalactosaminyltransferases Female business 030217 neurology & neurosurgery |
| Zdroj: | Experimental neurology. 311 |
| ISSN: | 1090-2430 |
| Popis: | Parkinson's disease is a neurodegenerative disorder that reduces a patients' quality of life by the relentless progression of motor and non-motor symptoms. Among the non-motor symptoms is a condition called neurogenic bladder that is associated with detrusor muscle underactivity or overactivity occurring from neurologic damage. In Parkinson's disease, Lewy-body-like protein aggregation inside neurons typically contributes to pathology. This is associated with dopaminergic neuron loss in substantia nigra pars compacta (SNc) and in ventral tegmental area (VTA), both of which play a role in micturition. GM1 gangliosides are mature glycosphingolipids that enhance normal myelination and are reduced in Parkinson's brain. To explore the role of mature gangliosides in vivo, we obtained GM2 Synthase knockout (KO) mice, which develop parkinsonian pathology including a loss of SNc dopaminergic neurons, which we reconfirmed. However, bladder function and innervation have never been assessed in this model. We compared GM2 Synthase KO and wild type (WT) littermates' urination patterns from 9 to 19 months of age by counting small and large void spots produced during 1 h tests. Because male and female mice had different patterns, we evaluated data by sex and genotype. Small void spots were significantly increased in 12–16 month GM2 Synthase KO females, consistent with overactive bladder. Similarly, at 9–12 month GM2 KO males tended to have more small void spots than WT males. As GM2 Synthase KO mice aged, both females and males had fewer small and large void spots, consistent with detrusor muscle underactivity. Ultrasounds confirmed bladder enlargement in GM2 Synthase KO mice compared to WT mice. Tyrosine hydroxylase (TH) immunohistochemistry revealed significant dopaminergic loss in GM2 Synthase KO VTA and SNc, and a trend toward TH loss in the GM2 KO periaqueductal gray (PAG) micturition centers. Levels of the nerve growth factor precursor, proNGF, were significantly increased in GM2 Synthase KO bladders and transmission electron micrographs showed atypical myelination of pelvic ganglion innervation in GM2 Synthase KO bladders. Cumulatively, our findings provide the first evidence that mature ganglioside loss affects micturition center TH neurons as well as proNGF dysregulation and abnormal innervation of the bladder. Thus, identifying therapies that will counteract these effects should be beneficial for those suffering from Parkinson's disease and related disorders. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect